---
title: "Iovance Biotherapeautics (IOVA.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/IOVA.US/norm.md"
symbol: "IOVA.US"
name: "Iovance Biotherapeautics"
parent: "https://longbridge.com/en/quote/IOVA.US.md"
datetime: "2026-05-20T20:22:54.125Z"
locales:
  - [en](https://longbridge.com/en/quote/IOVA.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/IOVA.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/IOVA.US/norm.md)
---

# Iovance Biotherapeautics (IOVA.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.1889 | -0.1767 | -0.2507 | -0.3338 | -0.3598 |
| ROE | -44.52% | -41.06% | -52.12% | -60.92% | -62.86% |
| Revenue | 71.43M | 86.77M | 67.45M | 59.95M | 49.32M |
| Net income | -79.05M | -71.90M | -91.25M | -111.66M | -116.16M |
| Operating income | -81.04M | -73.46M | -89.76M | -113.77M | -121.22M |
| Gross margin | 40.50% | 50.32% | 42.96% | 5.48% | 13.40% |
| Net margin | -110.66% | -82.87% | -135.28% | -186.25% | -235.51% |
| Profit quality | - | - | - | - | - |

## Balance Sheet (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| A&L | 925.66M | 913.17M | 904.95M | 907.44M | 966.74M |
| Leverage | 1.28 | 1.31 | 1.29 | 1.30 | 1.26 |
| BVPS | 1.65 | 1.70 | 1.82 | 2.04 | 2.30 |
| Turnover | 0.3018 | 0.2890 | 0.2642 | 0.2581 | 0.2316 |
| Cash & STI | 313.44M | 296.98M | 300.80M | 301.18M | 359.71M |
| Inv & Rec | 58.38M | 51.68M | 51.71M | 49.83M | 65.55M |
| LT assets | 175.78M | 177.01M | 175.41M | 172.42M | 162.49M |
| Net debt | -265.67M | -247.54M | -248.31M | -248.02M | -305.99M |

## Cash Flow Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -72.07M | -52.56M | -78.70M | -67.45M | -103.69M |
| Investing CF | 11.39M | 775000.00 | 17.01M | 13.84M | 15.87M |
| Financing CF | 94.33M | 56.17M | 88.06M | 13.23M | 143.31M |
| Free CF | -50.72M | -33.38M | -52.92M | -12.18M | -64.07M |
| OCF coverage | -1090.71% | -564.00% | -725.77% | -903.99% | -1669.52% |
| Repaid & issued | - | - | - | - | - |
| CapEx | -6.61M | -9.32M | -10.84M | -7.46M | -6.21M |